DIA 2013 49th Annual Meeting
Click here to go to the previous page
A Comparison of Study Startup Regulations and Timelines in Several Major Emerging Markets and the Decision Process for Selection
Track
:
Track 08:Regulatory Affairs and Submissions
Program Code:
337
Date:
Wednesday, June 26, 2013
Time:
10:15 AM to 11:45 AM
EST
Location:
253A
CHAIR
:
David Passov, MBA (SCHNON), Senior Vice President, Eastern Europe, ClinStar, A PRA Company, United States
SPEAKER
(S):
Ori Ben-Yehuda, MD,FACC (SPKSUP), Professor of Clinical Medicine; Director, Coronary Care Unit, University of California, San Diego, United States
Robert A. Baughman, PharmD,PhD (SPKNON), Senior Vice President, Clinical Sciences, MannKind Corporation, United States Nancy Widener, MS (SPKNON), Executive Director, Clinical Science and Operations, Bristol-Myers Squibb Company, United States
Description
The panel will explore conventional definitions of emerging markets; critique advantages and challenges of conducting trials in these markets; and examine study startup regulations/timelines and the decision-making process for entering these markets.
This session is a part of:
This session is a part of: